Why Astrana Health, Inc.’s (ASTH) Stock Is Down 6.58%
As of Wednesday, September 23, Astrana Health, Inc.’s ASTH share price has dipped by 6.58%, which has investors questioning if this is right time to buy.Rosalio Madrigal
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Jenna Brashear
Cynthia McLaughlin
Jenna Brashear
Jenna Brashear
| Share Statistics | ASTH | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,965.1 | $1,695.3 | 54% |
|
| Shares Out (Mil) | 49.8 | 81.4 | 47% |
|
| Institutional Ownership | 85.6% | 87.8% | 53% |
|
| Float (Mil) | 38.8 | 57.1 | 41% |
|
| Beta | 0.90 | 0.78 | 54% |
|
| Avg Daily Volume (000s) | 345 | 551 | 52% |
|
| Price Change (52-week) |
26.2% | 79.1% | 73% |
|
| Growth | ASTH | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 35.9% | 10.4% | 92% |
|
| Net Income (5yr) | (9.8%) | (0.7%) | 29% |
|
| EPS (5yr) | (14.6%) | 1.2% | 19 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 3.7% | (17.3%) | 67% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 3 | 3 | 3 | |
| Current EPS | $0.877 | $3.067 | $3.637 | |
| Month Ago EPS | $0.860 | $3.040 | $3.540 | |
| # Rev Up | 0 | 1 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | $0.790 | $2.920 | $3.420 | |
| Year/Year Chg | 119.3% | 569.7% | 889.1% | |
| Financials | ASTH | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $3,844 | $1,505 | 70% |
|
| Net Income (TTM) (Mil) | $41 | $26 | 53% |
|
| EPS (TTM) | $0.825 | $0.200 | 59% |
|
| Operating Cash Flow (TTM) (Mil) | $108 | $165 | 53% |
|
| Net Cash Flow (TTM) (Mil) | $65 | $2 | 73% |
|
| Long-Term Debt (Q1) (Mil) | $917 | $394 | 65% |
|
| Enterprise Value (Q1) (Mil) | $2,361 | $2,238 | 51% |
|
| Valuation | ASTH | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.28 | 2.97 | 58% |
|
| P/E | 46.8 | 25.8 | 84% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | ASTH | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 10.5% | 27.0% | 10% |
|
| Net Margin | 1.1% | 1.2% | 35% |
|
| ROA | 2.2% | 2.0% | 57% |
|
| ROE | 5.1% | 6.9% | 44% |
|
| Liabilities to Assets | 73.8% | 60.8% | 69% |
|
| F-Score | 6 | 5 | 67% |
|
Astrana Health, Inc. did not pass any screens on 10/12/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors